Yancey et al., 1978 - Google Patents
Motility of the pathogen and intestinal immunity of the host in experimental choleraYancey et al., 1978
- Document ID
- 7912447897777190769
- Author
- Yancey R
- Berry L
- Publication year
- Publication venue
- Secretory Immunity and Infection: Proceedings of the International Symposium on the Secretory Immune System and Caries Immunity
External Links
Snippet
Previous studies from our laboratory have shown that motility is an important virulence factor for V. cholerae. Guentzel and Berry (1) observed that fully toxigenic and prototrophic, non- motile mutants were less able to cause disease following oral challenge in suckling mice …
- 230000004899 motility 0 title abstract description 12
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Levine et al. | Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine | |
| Baqar et al. | Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice | |
| Clements et al. | Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas | |
| JP3911058B2 (en) | Streptococcus Ex vaccine | |
| Arko et al. | Neisseria gonorrhoeae: effects of systemic immunization on resistance of chimpanzees to urethral infection | |
| Oyston et al. | Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague | |
| EP1702927B1 (en) | Attenuated microorganisms for the treatment of infection | |
| JP2004159660A (en) | Deletion mutants as cholera vaccines | |
| US10369207B2 (en) | Prevention of pertussis using adenylate cyclase deficient Bordetella strains | |
| Cray Jr et al. | Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1 | |
| Pierce et al. | Protection against experimental cholera by antitoxin | |
| Yancey et al. | Flagella-induced immunity against experimental cholera in adult rabbits | |
| Pierce et al. | Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits | |
| Tamura et al. | Effect of antiflagellar serum in the protection of mice against Clostridium chauvoei | |
| ATE170755T1 (en) | PRESENTATION AND USE OF E. COLI BACTERIA KILLED WITH FORMALIN, WHICH EXPRESS THE COLONY FACTOR ANTIGEN (CFA) FOR VACCINATION AGAINST THE INTESTINAL BACTERIA E. COLI, WHICH CAUSES INTESTINE INFECTION/DIARRHEA IN HUMANS | |
| Bratthall et al. | Antigenic variation of Streptococcus mutans colonizing gnotobiotic rats | |
| Sack et al. | Oral immunization of rabbits with enterotoxigenic Escherichia coli protects against intraintestinal challenge | |
| Maheswaran et al. | Studies on Pasteurella multocida. I. Efficacy of an avirulent mutant as a live vaccine in turkeys | |
| Yancey et al. | Motility of the pathogen and intestinal immunity of the host in experimental cholera | |
| Spira et al. | Colonization of the rabbit small intestine by clinical and environmental isolates of non-O1 Vibrio cholerae and Vibrio mimicus | |
| de la Cabada et al. | Immunoprotection against enterotoxigenic Escherichia coli diarrhea in rabbits by peroral administration of purified colonization factor antigen I (CFA/I) | |
| WO2020049133A1 (en) | Adenylate cyclase catalytic domain deficient bordetella strains | |
| Isogai et al. | Phagocytosis as a defense mechanism against infection with leptospiras | |
| US6019981A (en) | Modified live Edwardsiella ictaluri against enteric septicemia in channel catfish | |
| Tokunaga et al. | Compared colonizing and immunizing efficiency of toxinogenic (A+ B+) Vibrio cholerae and an A-B+ mutant (Texas Star-SR) studied in adult rabbits |